Nuvectis Pharma, Inc.

NVCT ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
EFFECT Aug 28, 2026
S-3 Aug 21, 2026 FORM S-3
8-K Aug 21, 2026 FORM 8-K
SCHEDULE 13G Aug 6, 2026
4 Aug 5, 2026 OWNERSHIP DOCUMENT
10-Q Aug 4, 2026 10-Q
8-K Aug 4, 2026 FORM 8-K
4 Jul 1, 2026 OWNERSHIP DOCUMENT
4 Jul 1, 2026 OWNERSHIP DOCUMENT
8-K Jun 30, 2026 FORM 8-K
424B5 Jun 30, 2026 424B5
424B5 Jun 29, 2026 424B5
8-K Jun 29, 2026 FORM 8-K
8-K Jun 23, 2026 FORM 8-K
4 Jun 12, 2026 OWNERSHIP DOCUMENT
4 Jun 12, 2026 OWNERSHIP DOCUMENT
4 Jun 12, 2026 OWNERSHIP DOCUMENT
4 Jun 12, 2026 OWNERSHIP DOCUMENT
8-K Jun 12, 2026 FORM 8-K
10-Q May 5, 2026 10-Q
8-K May 5, 2026 FORM 8-K
DEFA14A Apr 27, 2026 DEFA14A
DEF 14A Apr 27, 2026 DEF 14A
EFFECT Feb 20, 2026
CORRESP Feb 18, 2026
← Newer Page 1 of 11 · 273 filings Older →